{"id":966760,"date":"2026-05-26T08:16:04","date_gmt":"2026-05-26T12:16:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/"},"modified":"2026-05-26T08:16:04","modified_gmt":"2026-05-26T12:16:04","slug":"mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/","title":{"rendered":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CARMEL, Ind. and BURLINGTON, Mass., May  26, 2026  (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at the Jefferies 2026 Global Healthcare Conference in New York City.<\/p>\n<p>The presentation will take place on Wednesday, June 3, 2026, from 8:10 a.m. to 8:40 a.m. ET.<\/p>\n<p>The live webcast can be accessed under the Events section of the MBX Biosciences website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u33w-SEXBxLaEJi0gUapZp46_HLwEB4cf-SJmDcKKmlie_VV0Sw896Xzx1-vC81B8AxDbQk6smWrIw9HVi9u-3VPDd-sa9_b5IWL6zPw2F6dVVsL0QjQgT-g3STOsMBe9eIUTDv6oaQrQs81Z1S12Z1lapi8XJitqflxbFDJRv0=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.mbxbio.com\/news-events\/events<\/a>. A replay of the webcast will be accessible approximately two hours following the conclusion of the presentation and will remain archived on the Company\u2019s website for approximately 90 days.<\/p>\n<p>\n        <strong>About MBX Biosciences<\/strong>\n      <\/p>\n<p>MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP\u2122 platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company\u2019s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism preparing for Phase 3 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development and MBX 5765 in preclinical development, as well as additional discovery candidates. The Company is based in Carmel, Indiana and Burlington, Massachusetts. To learn more, please visit the company website at www.mbxbio.com and follow it on LinkedIn.<\/p>\n<p>\n        <strong>Media Contact:<\/strong>\n      <\/p>\n<p>George Shea<br \/>We. Communications<br \/>gshea@wecommunications.com<br \/>(937) 232-4889<\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Jim DeNike<br \/>MBX Biosciences<br \/>jdenike@mbxbio.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODE2YzliZGItNzAxZi00NTUzLTg0YTUtMzRmNzUxZGFhZWMwLTEyNTY5MjctMjAyNi0wNS0yNi1lbg==\/tiny\/MBX-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARMEL, Ind. and BURLINGTON, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at the Jefferies 2026 Global Healthcare Conference in New York City. The presentation will take place on Wednesday, June 3, 2026, from 8:10 a.m. to 8:40 a.m. ET. The live webcast can be accessed under the Events section of the MBX Biosciences website at https:\/\/investors.mbxbio.com\/news-events\/events. A replay of the webcast will be accessible approximately two hours following the conclusion of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-966760","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CARMEL, Ind. and BURLINGTON, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at the Jefferies 2026 Global Healthcare Conference in New York City. The presentation will take place on Wednesday, June 3, 2026, from 8:10 a.m. to 8:40 a.m. ET. The live webcast can be accessed under the Events section of the MBX Biosciences website at https:\/\/investors.mbxbio.com\/news-events\/events. A replay of the webcast will be accessible approximately two hours following the conclusion of the &hellip; Continue reading &quot;MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T12:16:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City\",\"datePublished\":\"2026-05-26T12:16:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/\",\"name\":\"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\",\"datePublished\":\"2026-05-26T12:16:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/","og_locale":"en_US","og_type":"article","og_title":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk","og_description":"CARMEL, Ind. and BURLINGTON, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at the Jefferies 2026 Global Healthcare Conference in New York City. The presentation will take place on Wednesday, June 3, 2026, from 8:10 a.m. to 8:40 a.m. ET. The live webcast can be accessed under the Events section of the MBX Biosciences website at https:\/\/investors.mbxbio.com\/news-events\/events. A replay of the webcast will be accessible approximately two hours following the conclusion of the &hellip; Continue reading \"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-26T12:16:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City","datePublished":"2026-05-26T12:16:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/","name":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=","datePublished":"2026-05-26T12:16:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNTQ4NSM3NjE3OTAxIzIyNDUzNzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=966760"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966760\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=966760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=966760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=966760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}